chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever/was 102 and it got down to 100.  It is now 99.9-100; nose will not stop running; thought throat was swollen; throat is scratchy and sore; throat is scratchy and sore; severe headche; vomiting; diarrhea; feels like crap; This is a spontaneous report from a contactable consumer (patient).  A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included allergic to bees from an unknown date. The patient's concomitant medications were not reported. Last night (on 20Apr2021), he started having severe headache, vomiting, and he had diarrhea and just felt like crap. The patient's fever was 102 and it got down to 100.  It was now 99.9-100. The patient clarified that last night (on 20Apr2021) he thought his throat was swollen like when he got stung by a bee.  He was allergic to bees and that was how his throat felt, but it did not constrict all the way. It was scratchy and sore now.  The patient added that his finger tips feels, and then pauses sentence and stated he did not know and that his nose would not stop running. The patient confirmed that he was calling about the Pfizer Covid19 vaccine and he just wanted to make sure that Pfizer knows this, and that he was assuming he was going to be okay and this was going to pass by. The outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Breakthrough case admission after 2 vaccines Moderna 2/5/21 Lot# 007M20A;  Moderna 3/4/21 Lot# 023M20A
Left facility 15 min after injection by the time I got home  - The area between my nose and upper lip and lip swelled up and became numb . Over the next few days had small hives over trunk ,arms and legs  I took 50 mg of Benadryl  as soon as symptoms started and for approx 5 days . Also used ice to lip and hives  The Benadryl controlled the symptoms . I had epi pens at home but did not use them  - I also live 2 min from Hosp so I felt safe staying at home and monitoring symptoms .  Never had any resp distress or difficulty swallowing .Not sure if this had anything to do with immunization  or reaction but I had kidney stone that was diag 9 days after injection ( never had  any kidney stones prior to ) did have fever with injection - maybe dehydration caused issue with stone
Patient was accidentally given the 2nd dose in the Moderna vaccine series at 21 days instead of 28 days. Patient reported to us 8 days after getting the dose that they have had vomiting issues for 3 days.  Patient was triaged by a nurse and deemed stable and not in need to go to ER. Patient will come into clinic to be evaluated further.
10 days after getting the first dose, I experiences a severe headache in the forehead and front/top crown area. It lasted for over 24 hours. At 2:45 AM on 2-1-21, the pain was so bad that I fainted.
Patient was not vaccinated according to timing recommendations from the CDC. Patient received their COMIRNATY vaccine too soon after receiving their Bivalent vaccine (only one month apart).
This spontaneous report as received from a registered nurse refers to a 54 year old female patient with allergy to codeine and allergy to "sulfa drugs". The patient's medical history included chronic history of shingles recurrence. On 26-Nov-2013, the patient was vaccinated with ZOSTAVAX 19400 plaque forming unit (PFU) lot # J006158, expiration date: 30-AUG-2014 (dose and route were not reported) for preventions of shingles recurrence. Concomitant therapies included Zoloft, Zolpidem and Valtrex. On 03-DEC-2013, the patient experienced shingles again. The nurse reported that the patient was prescribed Valtrex the same day that she received ZOSTAVAX but did not know if the patient was using the medications at that time. Treatment was not given for shingles. Lab studies were not performed. The patient called her doctor's office to seek medical attention. The outcome of the patient experiencing shingles again was reported as not recovered. Causality was not reported. Additional information has been requested.
Date vial was initially stored in the refrigerator 18-FEB-2022; Gave doses from a vial 1 day past the beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave doses from a vial 1 day past the beyond use date) and PRODUCT STORAGE ERROR (Date vial was initially stored in the refrigerator 18-FEB-2022) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave doses from a vial 1 day past the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date vial was initially stored in the refrigerator 18-FEB-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave doses from a vial 1 day past the beyond use date) and PRODUCT STORAGE ERROR (Date vial was initially stored in the refrigerator 18-FEB-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. Paitent gave dose from a vial 1 day past the beyond use date 20-MAR-2022. It had been reported that  Date the vial was initially stored in the refrigerator 18-FEB-2022. The vial did not undergo any temperature excursions. No treatment medication reported.   This case was linked to MOD-2022-518727 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2022: Follow up received contain Non-significant information.
Received smallpox vaccine 8/25/03, major reaction read on 9/2/03 with erythema surrounding non streaky left arm. On 9/4/03 presented +LA, red warm streaking and deltoid to left axilla. Rx with Tequin 400mg po each hour #5, RTC 9/8/03 - erythematous streaking resolving, scab form at smallpox site - LA.
Both legs started to burn; Both legs started to burn then tingle; A nickle sizelump appeared on my calf and isextremely painful to the tough. It isvery hard all around the lump andfeels like a coin under the skin.; A nickle sizelump appeared on my calf and isextremely painful to the tough. It isvery hard all around the lump andfeels like a coin under the skin.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 31Mar2021 at 15:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included pseudoephedrine sulfate, loratadine (CLARITIN D 12 HOUR) for unknown indication from an unknown date. The patient had no known allergies to medications, food, or other products. The patient previously, received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration on 11Mar2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 21:00, 6 hours after injection the patient experienced burning sensation in both legs then tingle, immediately after that, a nickle size lump appeared on the calf. The lump was extremely painful to the touch, that was very hard all around the lump and felt like a coin under the skin. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events burning leg, tingling, nodule and painful nodule were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rash on arm in area of injection, followed over the next days by myalgias, chills, sweats, malaise and fatigue, and on 8/16 by cough.  White blood cells are elevated at 14.5.  She has a rash that could be cellulitis, but several smaller circular rashes a few cm away from the main rash also.  Drug reaction vs cellulitis vs both suspected.
Inability to lift arm; Fatigue; Achy back; Headache; dizziness; Mild loss of taste and smell; Mild loss of taste and smell; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received  first dose pneumococcal 13-val conj vac (dipht crm197 protein) (PREVENAR 13), via an unspecified route of administration on 29Oct2020 at single dose for immunisation and influenza vaccine via an unspecified route of administration on 14Oct2020 at single dose for immunisation. The patient's medical history included  asthma. Concomitant medications were not reported. The patient experienced side effects include inability to lift arm, fatigue, achy back, headache and dizziness. Also experienced mild loss of taste and smell. Event took place after use of product on an unknown date. This is the patient first time getting Prevnar-13 vaccine. The patient also received flu vaccine on 14Oct2020. The patient has asthma and takes Dupixent injections every 2 weeks. Last dose was 20Oct2020.The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
locally-situated rash; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team.  A 16-year-old female patient received meningococcal group b Rlp2086 (TRUMENBA), on 11Apr2022 as 0.5 ml, single (Lot number: AT1920, Expiration Date: May2022) at the age of 16 years, in left arm for immunisation; meningococcal vaccine (MENINGOCOCCAL VACCINE), on 11Apr2022 as 0.5 ml, single (Lot number: U6920AB, Expiration Date: 15Apr2022), in left arm for immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: meningococcal vaccine (Dose 1), administration date: 16Nov2016, for vaccination. The following information was reported: RASH (non-serious) with onset 16Apr2022, outcome "recovering", described as "locally-situated rash". Therapeutic measures were not taken as a result of rash.  Additional information: The patient developed the rash on the 16th. She has not seen the rash, but the mom said when she called that the rash was around the area of the site and was kind of raised a little bit, and it never spread anywhere else other than to the arm of where injections were. She thinks it got better. She clarified that this was her first dose of Meningitis B. It was the patient's second dose of NCV vaccine. She said her first dose of NCV vaccine was given 16Nov2016, and the patient wasn't their patient at that time, they do not have NDC/LOT/EXP to provide for that dose, only the date it was given.  No follow-up attempts are possible. No further information is expected.
I woke up drenched in sweat with a 103.5 degree fever. My head was throbbing wth short stabbing pains behind eyes and in temples. I was completely exhausted, w/ incredibly aching and weak legs. I had a sharp pain in the deep part of my left calf which came every seven seconds. I had a really sore neck, sore throat and my neck was riddled with swollen lymph nodes and cyst-like inflammation. This lasted three days. Ibuprofen gave temporary relief and dropped my temp to 101, but temp went back up the second it wore off.
Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/26/2022 Discharge Date: Dec 29, 2022 COVID positive 12/26/2022 PRESENTING PROBLEM: Syncope and collapse [R55] Hypoxemia [R09.02] Hyponatremia [E87.1] COVID [U07.1] Transient loss of consciousness [R55]   HOSPITAL COURSE: Patient is a 85 yo male with PMH of right ureteral obstruction with suprapubic catheter, TIA, SIADH, essential HTN and COPD. He presented to the ED after having 2 separate instance of transient loss of consciousness which had been preceded by 2 days of congested cough and fever.  In the ED patient tested positive for COVID-19 and was noted to be hypoxic with ambulation and was admitted to the medicine service.   # Transient LOC Secondary to Hypoxia Due to COVID-19 CXR was obtained in the ED without acute cardiopulmonary process. He was started on Decadron and Remdesivir and placed on pharmacological VTE prophylaxis. Patient had no further episodes of TLOC or hypoxia. Cardiac echo was obtained to help rule out other causes and was largely unremarkable. CTA thorax was not pursed as PE was felt low on differential given lack of tachycardia and quick resolution of symptoms with steroid therapy. He was discharged on Decadron to complete therapy to prevent rebound of symptoms
This spontaneous report was received from an office manager and refers to a 12 months old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 22-NOV-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested. Sender's Comments: US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515:  US-009507513-1704USA004516: US-009507513-1704USA004517.
15 minutes post vaccine went back to pharmacy experiencing racing heart and dizziness.  Pharmacists noticed hives on chest and back and took vitals.  I was laid on the floor and declined the epi pen.  tightness in chest, difficulty breathing, feeling like passing out, shaking.  highest heart rate was 200 bpm and blood pressure was 175/110.  benedryl (50mg) was administered and medics called.  Transported to hospital via ambulance.  Hospital administered steroids upon arrival.  EKG's were taken in an ambulance and again at the hospital.  diagnosis of anaphylactic reaction and advised not to receive further vaccinations for Covid or mRNA.  fatigue and heart palpitations over the next few days.  5 days later the high blood pressure (156/100) and pulse (110bpm) reoccured and I went to the emergency room.  Currently wearing heart monitor.
Hives, Itching that started at approximately 10pm on day of vaccination and has been getting progressively worse.    Advised to take antihistamines. Awaiting for further guidance from MD.
Localized swelling, heat & redness; lasted approx 1 wk; No prior vax;
Waves of nausea starting approximately 12.5 hours after vaccine dose received.  General malaise and feeling "faint" though blood pressure, temperature, heart rate, respiration and pulse oximetry WNL.
she got sick; This is a spontaneous report from a contactable consumer (patient).   A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection,  Batch/Lot Number: Not Provided), via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient got sick, will not be taking her second dose.  Patient stated reports that her husband has been sick for months after getting the first Covid vaccine shot, she had her first dose as well and would not be taking her second dose since her husband has developed symptoms after getting the first dose and wanted to speak to someone to help her husband to heal. She had to get it, the company that she worked for said if she do not got it she would not get paid. She got sick but do not got as bad as him, symptoms lasted 3 days, then she was out of bed. The outcome of events she got sick was recovered on an unspecified date.   Information about batch/Lot number has been requested.
C/O swelling, discomfort right jaw and neck 09/08/2005. Temperature 102.1 09/08/2005 Saw Dr. an of 09/09/2005 states thinks child is having a reaction to MMR administered on 08/22/2005. Was advised to alternate Tylenol and Ibuprofen for fever and discomfort.
less than half of second dose administered to patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (less than half of second dose administered to patient) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 10-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (less than half of second dose administered to patient). At the time of the report, INCORRECT DOSE ADMINISTERED (less than half of second dose administered to patient) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported. Action taken with mRNA-123 is not applicable.
Urinary tract infection; Broken wrist; broken right second toe; swollen lymph nodes; fractured left foot; covid vaccine/injection site itching; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Urinary tract infection), FOOT FRACTURE (fractured left foot), WRIST FRACTURE (Broken wrist), FOOT FRACTURE (broken right second toe) and VACCINATION SITE PRURITUS (covid vaccine/injection site itching) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced VACCINATION SITE PRURITUS (covid vaccine/injection site itching). On 01-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FOOT FRACTURE (fractured left foot). On an unknown date, the patient experienced URINARY TRACT INFECTION (Urinary tract infection), WRIST FRACTURE (Broken wrist), FOOT FRACTURE (broken right second toe) and LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, URINARY TRACT INFECTION (Urinary tract infection), FOOT FRACTURE (fractured left foot), WRIST FRACTURE (Broken wrist), FOOT FRACTURE (broken right second toe) and VACCINATION SITE PRURITUS (covid vaccine/injection site itching) outcome was unknown and LYMPHADENOPATHY (swollen lymph nodes) had not resolved.            No concomitant drug information was provided.  It was unknown if the patient was enrolled in COVID-19 trial. The causality of the events with respect to SKYRIZI was not reported.  No treatment drug information was provided.
Vaccinated on 05/10/01. Died-apparent SIDS 06/11/01. Was totally normal. Put down to nap and found dead two hours later. Mom requesting VAERS be notified.
2-3 DAYS AFTER INJECTION, HER R ARM BECAME HOT, HARD AND SWOLLEN TO SIZE OF GOLF BALL. HAS DR APPT AUG 13TH.
3/03/21 The injection site, had redness, stiffness, soreness, and swelling for two weeks.  Hard to move and lift my arm, difficulty sleeping on the left side.  Ice and motrin helped.  Pain and swelling with the first shot.  Second shot 3/31/21 injection site same as the first tender and swelling at the injection site.   Had to take Benadryl and other allergy OTC medicine for two weeks because of severe itching and rash-like symptoms.
Patient received covid vaccine and fainted minutes after receiving the vaccination. Patient stated they felt lightheaded and head was "buzzing". After patient fainted stated that they felt better, ambulance arrived and took over patient care.
Moderna COVID-19 Vaccine EUA Fever between 100F and 101.1F, muscle aches, joint aches, chills and shivering, fatigue, headache, acute pain in pit of  stomach, nausea. All for the last 24 hours.  Took the maximum recommended dose of Tylenol  (6 pills in a 24 hour period). Fever was reduced but didn?t go away completely.